Evotec SE today announced the financial results and corporate updates for the first quarter 2021. Group revenues from contracts with customers increased by 11% to € 133.1 m (Q1 2020: € 119.4 m); Base business growth of 28%, adjusted for the end... Read more Ticker: EVOTF CIK: 1412558. View differences made from one year to another to evaluate Evotec Ag's financial trajectory. Sample 10-K Year-over-Year (YoY) Comparison. Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Evotec Ag Im Oktober 2020 erhielt Evotec eine Finanzspritze von der Stiftung des Microsoft-Gründers Bill Gates für die Entwicklung eines Corona-Medikaments in den USA. Über die Höhe der Förderung, die Evotec im Rahmen einer sogenannten COVID-19 Therapeutic Accelerator Initiative erhält, ist bislang nichts bekannt
Annual reports. Annual Review 2019. Annual report 2018. Annual report 2017. Annual report 2016. Annual report 2015. Annual report 2014. Annual report 2013. Annual report 2012 These risks and uncertainties are more fully described in our filings with the Securities and Exchange Commission, including in the section entitled Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2020, and subsequent reports that we file with the Securities and Exchange Commission
.09 MB. 2018. Annual Report 2018 PDF Format Download (opens in new window) PDF 8.61 MB. 2017. Annual Report 2017 PDF Format Download (opens in new window) PDF 3.12 MB. 2016. Annual Report 2016 PDF Format Download (opens in new window) PDF 5.96 MB. 2015 . Annual Report 2015 PDF Format Download (opens in new window) PDF 3.60 MB. This annual ESG Report is designed to summarize our work on key topics that we and our stakeholders view as important to our business, and to guide readers to where they can access more detailed information about specific topics of interest. All data in this report are as of December 31, 2019, unless otherwise noted
Analyst / Investor Presentation: Annual Financial Report 2019 English | 26.03.2020 | Download PDF (2.3 MB) Präsentation zur Bilanzpressekonferenz SMA Solar Technology A An archive of The Estée Lauder Companies' Annual Reports. Date Title Title; Jun 30, 2020: 2020 Annual Report: opens in a new window Click Here Jun 30, 2019
Annual Report 2019 Down-to-earth. Annual Report 2019; Our fiscal year 2018/19 in numbers. For more than 150 years, our work has always been in close partnership with the Earth: clean energy from hydropower, paper production from renewable raw materials and drive technology for efficient and environmentally friendly mobility. In this way, our technologies make a contribution to the sustainable. Annual Report About this report The audited annual accounts and consolidated accounts can be found on pages 38-51 and 62-121. The corporate governance report exam- ined by the auditors can be found on pages 52-61. Epiroc reports its sustainability work for 2019 according to the Global Reporting Initiative (GRI) Standards version 2016, Core option. The sustain - ability report has.
The following PDF files are available (PDF:) Covestro - Annual Report 2019 246 pages 13.5 MB (PDF:) BEYOND - Magazin Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today reported financial results and corporate updates for the fiscal year ended 31 December 2019. FINANCIALS REFLECT STRONG GROWTH. Group revenues up 19% to € 446.4 m (2018: € 375.4 m) Adjusted Group EBITDA up 29% to € 123.1 m (2018: € 95.5 m Evotec SE Unternehmen; Aktie; Downloads; Interaktiv ; IR-Kontakte; Geschäftsberichte Quartalsberichte Corporate Governance Dokumente. Geschäftsberichte. Bezeichnung: Dateiformat: Sprache: Größe: Annual financial report 2020 English 4.59 MB Jahresfinanzbericht 2020 ZIP German 21.55 MB Jahresfinanzbericht 2019 German 4.00 MB Annual financial report 2019 English 3.79 MB Jahresfinanzbericht. Evotec annual revenue increased from €446.4 million in 2019 to €509.9 million in 2020, a (14.2%) increase. Find detailed stats on Evotec revenue on Craft
HAMBURG, GERMANY / ACCESSWIRE / March 19, 2020 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report its financial results for 2019 on Thursday, 26 March 2020. Evotec recorded a net result for the financial year 2020 of € 6.3 m (2019: € 37.2 m). Evotec ended the year 2020 with a net debt position of € 10.0 m versus € 143.1 m at the end of 2019. The massive improvement is mainly due to the capital increase by Mubadala Investment Company and Novo Holdings of € 250 m in October more than compensating for higher investments related to the ramp.
Evotec market cap is €5.9 b, and annual revenue was €509.92 m in FY 2020. View Evotec stock / share price, financial statements, key ratios and more at Craft Evotec recorded a net result for the financial year 2020 of € 6.3 m (2019: € 37.2 m). Evotec ended the year 2020 with a net debt position of € 10.0 m versus € 143.1 m at the end of 2019.
Annual Report 2018. Cookies are blocked. You have to allow cookies to start the session. 03/28/2019 | 02:00 pm CET Evotec AG Annual Report 2018. Name*: E-Mail*: I have read the notice on the protection of my personal data and accept it. Organized by. In 2019, a gain of MNOK 107 was recorded related to the sale of Kongsberg Evotec, while MNOK 416 was recorded for total integration and restructuring costs. Risk reduction measures were implemented at an early stage to reduce the financial and operational effects of COVID-19. Furthermore, costs related to, among other things, travel and consultants have been minimal since the pandemic occurred. Evotec Revenue (Annual): 499.79M for Dec. 31, 2019. View 4,000+ financial data types. Browse.. The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. Furthermore, the Management Board will present an outlook for fiscal year 2020. The conference call will be held in English
Most Recent Annual Report. MOST RECENT 2020 Annual Report and Form 10K. View PDF View Form 10K (HTML) Enphase Energy Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available. Shipping Information. Please fill out the form below and click Place Order to complete your order. Name Email Street Address City. Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of December 31, 2019, Evotec had a market capitalization of €3.47 billion and a pipeline of more. Just - Evotec Biologics (former Just.Bio) was acquired effective July 02, 2019 and was fully consolidated in the Group numbers from the respective date onwards. Furthermore, effective 01 April 2020, Evotec GT started its operations. Hence, numbers for the first half-year 2019 and 2020 are not fully comparable. ABOUT EVOTEC S In depth view into Evotec Total Employees (Annual) including historical data from 1999, charts, stats and industry comps
Hamburg, Germany, 19 June 2019: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that its shareholders approved all proposals the Company's Management put to vote at the Company's Annual General Meeting 2019 with very strong supporting majorities Annual Report 2019 Download | PDF 2,4 MB; Geschäftsbericht 2019 Download | PDF 2,5 MB; Consolidated interim report from the Management Board within the second half of 2019 Download | PDF 0,1 MB; Konzern-Zwischenmitteilung der Geschäftsführung innerhalb des zweiten Halbjahres 2019 Download | PDF 0,1 MB; Interim financial report in accordance with Section 37w of the German Securities Trading. Evotec AG annual/quarterly other operating income or expenses history and growth rate from 2006 to 2021. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field. Evotec AG other operating income or expenses for the quarter ending March 31, 2021 were $0.019B.
EVOTEC Gebäudetechnik GmbH has its registered office in Vienna, Austria. Its current status is listed as active. The company is registered at the Commercial register at the local court of Vienna with the legal form of Private limited company (number FN 438275 y). The Commercial register entry was last updated on Feb 25, 2021. One director currently runs the company: 1 manager. The company. At present, the management of Evotec confirms the financial guidance published in the 2019 Annual Report on 26 March 2020 and confirmed in the Q1 Quarterly Statement on 14 May 2020 with regard to revenues and adjusted EBITDA
HAMBURG, GERMANY / ACCESSWIRE / August 7, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report its financial results for the first half of 2019 on. Evotec SE (OTCPK:EVOTF) Q2 2019 Earnings Conference Call August 14, 2019 8:00 AM ET. Company Participants. Werner Lanthaler - Chief Executive Officer. Enno Spillner - Chief Financial Officer.
Company, has a total of £1.5 million in annual funding available for research, and receives a share of revenues that arise from the commercialisation of analytical insights to reinvest back into local patient care providing them with an additional funding stream. The Sensyne Health model STRATEGIC REPORT Sensyne Health plc Annual Report 2019 Novo Holdings annual report 2018. Date. March 15, 2019. Location. Copenhagen. Novo Holdings made a profit of DKK 11.4 billion (EUR 1.5 billion) in 2018. It added 30 life science companies to its Investment Portfolio, valued at DKK 104 billion (EUR 14 billion) at the end of 2018 versus DKK 96 billion (EUR 12.9 billion) at the end of 2017 Konsensus-Erwartungen für GJ 2019/20 - 2022/23 - nach Q3 2019/20 Veröffentlichung (Englisch) Herunterladen - XLSX 43 KB . Ihre Ansprechpartner Stephanie Ritschel . Vice President Investor Relations +49 211 5408-7225 stephanie.ritschel _at_ ceconomy.de. E-Mail schreiben. Juli 2019 beschlossen, maximal bis zu 656.423 eigene Aktien der JDC Group AG über die Börse zurückzukaufen. Das Gesamtvolumen des Aktienrückkaufs ist auf maximal EUR 5 Mio. exklusive Nebenkosten festgelegt. Das Rückkaufprogramm soll spätestens zum 30. Juli 2020 beendet sein. Der Beschluss folgt der Ermächtigung der Hauptversammlung zum Erwerb eigener Aktien vom 24. August 2018. Die. 2019; 2018; 2017; 2016; 2015; 2014; 2013; 2012; 2011; 2010; Press Photos; Contact; E-mail alert. Information on data; Career . Working at Medigene; Jobs; DE. Investors & Media. Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and.
Abivax SA has been listed on the Paris Stock Exchange since 26 June 2015. ISIN code: FR0012333284. Symbol: ABVX. ICB Classification: Healthcare 4000/ Biotechnology 4573. Market: Euronext Paris-Compartment B. Type of Listing: continuous Evonik Sustainability Report 2019. SUSTAINABILITY REPORT 2018. Creating the future is our business. Evonik Sustainability Report 2018. SUSTAINABILITY REPORT 2017. Listening pays off. Sustainability Report 2017. SUSTAINABILITY REPORT 2016. Creating the exceptional. Sustainability Report 2016. SUSTAINABILITY REPORT 2015 . Perspective Change. Sustainability Report 2015. SUSTAINABILITY REPORT 2014. Annual financial report 2019 English 3.79 MB Jahresfinanzbericht 2018 German 2.91 MB Annual financial report 2018 English 2.86 MB Jahresfinanzbericht 2017 German 1.96 MB Annual financial report 2017 English 1.93 MB Jahresfinanzbericht 2016 German 1.82 MB Annual financial report 201 Annual financial report 2020 English 4.59 MB Jahresfinanzbericht 2020 ZIP German 21.55 MB Jahresfinanzbericht 2019 German 4.00 MB Annual financial report 2019 English 3.79 MB Jahresfinanzbericht 2018 German 2.91 MB Annual financial report 2018 English 2.86 MB Jahresfinanzbericht 201
. Hier finden Sie unseren aktuellen Finanzkalender, sowie verschiedene Publikationen (z.B. die Pressemitteilungen der FRoSTA AG, Finanzberichte, Geschäftsberichte usw.). Um alle Publikationen aus den jeweiligen Kategorien anzusehen, klicken Sie einfach auf die jeweilige Überschrift Annual Reports. In our annual reports we present the news of the respective business year. You can find all important facts and figures about our institute and our locations. In addition to exciting and forward-looking research projects, you will also gain an insight into the remarkable successes and events from the everyday research work of. Due to the COVID-19 pandemic, this year's Annual General Meeting was held as a purely virtual event. Under the topic 'Opening doors', Dr Werner Lanthaler, CEO and Enno Spillner, CFO of Evotec SE, presented the business performance as well as the highlights of the fiscal year 2019 and gave an overview about the further development of the Company
The annual financial statements and the combined management report of the Merck Group and Merck KGaA for 2019 are filed with the electronic German Federal Gazette (elektronischer Bundesanzeiger) and are available on the website of the German company register. This combined management report contains certain financial indicators such as operating result (EBIT), EBITDA, EBITDA pre, business free. Annual Report 2019 transform treatment options and grow in line with expectations. At the end of 2019, Veltassa® had been prescribed to more than 120,000 patients in the US and Europe. The positive results from the AMBER study showed Veltassa®'s potential to help patients with resistant hypertension and CKD and to maintain optimal treatment. › A.2.3.7 Änderungen der Organisations- und Segmentstruktur im Geschäftsjahr 2019 . Mit dieser fokussierten Aufstellung rückt OSRAM noch stärker an seine Märkte mit dem Ziel der Entwicklung von einem vertikal integrierten Lichtexperten zum Hightech-Photonik-Player. Photonik bedeutet im Wesentlichen die Erzeugung, Übertragung und Detektion von sichtbarem und unsichtbarem Licht und.
Evotec SE (EVT) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company Key Highlights Evotec SE (Evotec) is a drug discovery alliance and development partnership company. It discovers. Report with financial data, key executives contacts, ownership details & and more for Evotec Kereskedelmi Es Szolgaltato Kft. in Hungary. Report is available for immediate purchase & download from EMIS BRIEF-Evotec Expects 2020 EBITDA at last year's level between 100 to 120 Mln Eur * DGAP-NEWS: EVOTEC SE FISCAL YEAR 2019 RESULTS: EXCELLENT 2019 PERFORMANCE; VERY GOOD OUTLOOK FOR CONTINUED GROWTH. Evotec (UK) Limited is an active company incorporated on 19 December 1991 with the registered office located in Abingdon, Oxfordshire. Evotec (UK) Limited has been running for 29 years. There are currently 4 active directors and 1 active secretary according to the latest confirmation statement submitted on 22nd November 2020 Global Drug Discovery Services Market Study, 2019-2025, Featuring Profiles of Charles River Laboratories, GVK Biosciences, Evotec, Albany Molecular Research, Domainex, and GenScript Biotec
. English | 26.03.2020 | Download PDF (2.3 MB) Präsentation zur Bilanzpressekonferenz SMA Solar Technology AG. German | 26.03.2020 | Download PDF (2.7 MB) Präsentationen der SMA Gruppe 2019 Capital Market Story 2019. Analyst / Investor Presentation: Capital Markets Day 2019. English | 25.01.2019 | Download PDF (3.4 MB) Quartals. Im September 2019 schloss das Unternehmen eine überzeichnete Finanzierungsrunde zu 0,20 CAD pro Einheit ab und sammelte dabei rund 4,7 Mio. CAD ein. Anfang Oktober 2019 lagen wir mit dieser Empfehlung rund 35 Prozent im Gewinn. Die Freude währte aber nur kurz. Im Zuge der COVID-19-Panik fiel die Sernova-Aktie im Tief auf 0,09 CAD, kämpfte sich aber in der Zwischenzeit wieder nach oben und. April 2019 betrug das verwaltete Volumen der deutschen Fonds 39,6 Milliarden Euro. Das darin enthaltene Volumen der 21 zum öffentlichen Vertrieb zugelassenen Teilgesellschaftsvermögen (TGVs) betrug zum selben Stichtag 5,70 Milliarden Euro. Der vorliegende Jahresbericht informiert Sie detailliert über die Entwicklung unserer Indexfonds. Institutionelle und private Anleger schätzen iShares. In 2019, Evotec Innovate invested close to €65 million into R&D. Compared to 2018, this represents an increase of over 60%, and thus more than the ever invested into R&D on an annual basis
Report Overview. The global antibiotics market size was valued at USD 40.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. The rising prevalence of infectious diseases and supportive government legislation are the major drivers of the market. Moreover, an increase in antibiotic. EVOTEC (UK) LIMITED hat Ihre Tätigkeit zuvor unter dem Namen EVOTEC OAI LIMITED ausgeführt. Das Unternehmen ist mit dem SIC/NACE Code 72110 registriert. Das Unternehmen hat 4 Geschäftsführer und 1 Prokuristen. Die Bilanz wurde zuletzt am 31.12.2019 hinterlegt. Die jährliche Meldung erfolgte zuletzt am 22.11.2012.Die Firma kann schriftlich über 114 Innovation Drive, Milton Park erreicht. Evotec s.r.o. Short name: Country: Slovakia: City: Kuzmice: Address: 076 12 Kuzmice, Hlavná 18/37 : Date of establishment: 15/01/2016 : Capital subscribed: 13 516 EUR Date of the latest financial report: 31/12/2019: Net revenue: 143 998: Net revenue in EUR: 143 998: Date of the last number of employees data: 01/01/2017: Last number of employees data: 1 person: Number of owners: 1: Number of. HALF-YEAR REPORT 2019 3 CORPORATE Management Board contracts with Dr Cord Dohrmann (CSO) and Enno Spillner (CFO) extended, new Supervisory Board elected at Annual General Meeting 2019 with new members joining Evotec's Supervisory Board Conversion of the Company into European Company (SE) completed effective 29 March 2019 .6 m (31 Dec 2018: EUR 149.4 m), which was composed of cash and cash equivalents (EUR 111.6 m) and investments (EUR 30.0 m). Shortly after period-end, Evotec completed the repayment of the EUR 140 m debt bridge facility within less than two years after it was drawn down in context of the acquisition of Aptuit in August 2017, mainly due to.
. AGMs View. Kontakt. email@example.com. +49 (0) 89 9292 776 0. Investor Relations. Wir sind uns des großen Vertrauens, das unsere Investoren durch Ihren Aktienkauf in uns legen, und der damit verbundenen Verantwortung bewusst. Mit höchstmöglicher Transparenz möchten wir dieser Verantwortung gerecht werden. Übersicht und Strategie Financial Report H1 2021/Zwischenbericht für das 1.Halbjahr 2021. 2021. Sep 20, 2021. conference Berenberg Munich Conference - Munich. 2021. Sep 21, 2021. conference Baader 10th Investment Conference - Munich. 2021. Nov 15, 2021. puplications Financial Report Q3 2021/Zwischenbericht für das 3.Quartal 2021. 2022. Jan 10 - 12, 2022. conference Berenberg German Corporate Conference USA - New.
2019 Annual Report PDF / 7.93 MB 2019 Online Annual Report 2019 Full Year Results Report PDF / 1.9 MB 2019 Full Year Results Presentation PDF / 3.65 MB 2019 Half Year Results Report PDF / 2.5 MB 2019 Half Year Results Presentation PDF / 8.06 MB . 2018. 2018 Annual Report (PDF) PDF / 8.6 MB 2018 Online Annual Report 2018 Full Year Results Report PDF / 3.79 MB 2018 Full Year Results Presentation. EVOTEC SE : News, Nachrichten und Informationen Aktie EVOTEC SE | 566480 | DE0005664809 | Deutsche Boerse A Evotec SE Annual cash flow by MarketWatch. View EVOTF net cash flow, operating cash flow, operating expenses and cash dividends
Für Analysten. Und Zahlenfreunde. Alle Informationen über finanzielle und wirtschaftliche Entwicklungen Annual General Meeting: April 25, 2019: First quarter 2019 revenue: View Press Release >> Download the presentation >> February 21, 2019: Full Year 2018 results: View Press Release >> January 30, 2019: Atos Investor Day 2019: View Press Release >> Download presentations >> October 23, 2018: Q3 2018 revenue: View Press Release >> Download the presentation >> July 23, 2018: H1 2018 results: View.
in 2019 and ensure that we report on the most interesting and relevant matters. We also regularly re-evaluate the reporting aspects for materiality to ensure they continue to be current and complete. CSR REPORT 3 Galapagos NV. The four priority topics and material CSR aspects that we put forward are: Improving people's lives Science and innovation management Building partnerships to bring. Represented by the Board of Management: Ola Källenius (Chairman), Martin Daum, Renata Jungo Brüngger, Wilfried Porth, Markus Schäfer, Britta Seeger, Hubertus Troska, Harald Wilhelm Chairman of the Supervisory Board: Bernd Pischetsrieder Commercial Register Stuttgart, No. HRB 19360 VAT registration number: DE 81 25 26 31 WELLS FARGO MASTER TRUST - Wells Fargo Factor Enhanced International Portfolio reports 53.32% decrease in ownership of EVT / Evotec SE. 2020-10-28 - WELLS FARGO MASTER TRUST - Wells Fargo Factor Enhanced International Portfolio has filed a NPORT-P form disclosing ownership of 2,837 shares of Evotec SE (DE:EVT) with total holdings valued at $75,835 USD as of 2020-08-31 LSTM Annual Report 2019/2020. LSTM Annual Report 2019/2020. Search and overview. Search and overview. Close. Try. Features Fullscreen sharing Embed.
2019-09-09 sec.gov - 533 - Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Scope of the Report. The In Vitro ADME Testing Service Market, 2019-2030 report features a comprehensive study of the current landscape of in vitro ADME testing service providers. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders across different global regions. Amongst other elements, the report includes: A detailed assessment of the current. Evotec SE annual cash flow and in depth look at EVT.XE operating, investing, and financing activities C Citigroup Inc Annual Report of Employee Stock Plans (11-k) We have audited the accompanying statements of net assets available for benefits of the Citi Retirement Savings Plan for Puerto Rico (the Plan) as of December 31, 2020 and 2019, the related statements of changes in net assets available for benefits for the years then ended, and the related notes (collectively, the financial statements) As of 2019, the company has 22,514 employees and annual revenues of about €3.3 billion. Fraport was the main sponsor of the Bundesliga football team Eintracht Frankfurt from 2002 to 2012. Fraport AG is also involved in ground handling operations at its own operated airports and at third-party operated airports. It mostly operates ground handling services in a deregulated context. Fraport was.
Furthermore, the Annual General Meeting approved a resolution on creating contingent capital for the issue of subscription rights to Management Board members of Evotec AG, members of executive bodies of affiliated companies in Germany and abroad and selected executives of Evotec AG and affiliated companies in Germany and abroad as part of a Share Performance Plan 2017 (SPP 2017). Moreover, the. May 29, 2019. Annual General Meeting Munich. June 12, 2019. Roadshow London. June 13, 2019. Roadshow Hamburg. July 01, 2019. Roadshow Paris. August 06, 2019 . Publication of half-year report 2019; analysts' & investors' conference call. August 28, 2019. Commerzbank Sector Conference Frankfurt. September 24, 2019. Berenberg/Goldman Sachs German Corporate Conference Munich. November 07, 2019. EVOTEC SE : News, Nachrichten und Informationen Aktie EVOTEC SE | 566480 | DE0005664809 | Xetr Mit unserer Investor-Relations-Tätigkeit verfolgen wir das Ziel, alle bestehenden sowie potenziellen Stake- und Shareholder kontinuierlich und umfassend über die Entwicklung der freenet Group zu informieren. Dabei liegt der Fokus auf Transparenz und Integrität unserer Kapitalmarktkommunikation C Citigroup Inc Annual Report of Employee Stock Plans (11-k) We have audited the accompanying statements of net assets available for benefits of the Citi Retirement Savings Plan (the Plan) as of December 31, 2020 and 2019, the related statements of changes in net assets available for benefits for the years then ended, and the related notes (collectively, the financial statements)